LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 81.05 | 84.90 | 2749 | 8863 | 0.3101 | 0.6796 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 81.05 | 84.90 | 204 | 8863 | 0.0230 | 0.1397 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 81.05 | 84.90 | 2056 | 8863 | 0.2320 | 0.6084 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 82.75 | 84.90 | 2856 | 8621 | 0.3313 | 0.6945 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 82.75 | 84.90 | 2881 | 8621 | 0.3342 | 0.6968 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 82.75 | 84.90 | 227 | 8621 | 0.0263 | 0.1590 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 82.75 | 84.90 | 2241 | 8621 | 0.2599 | 0.6340 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 84.45 | 84.90 | 2935 | 8254 | 0.3556 | 0.7101 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 84.45 | 84.90 | 2965 | 8254 | 0.3592 | 0.7127 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 84.45 | 84.90 | 196 | 8254 | 0.0237 | 0.1351 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 84.45 | 84.90 | 2239 | 8254 | 0.2712 | 0.6414 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 86.16 | 84.90 | 3017 | 8141 | 0.3706 | 0.7201 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 86.16 | 84.90 | 3057 | 8141 | 0.3755 | 0.7235 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 86.16 | 84.90 | 203 | 8141 | 0.0249 | 0.1416 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 86.16 | 84.90 | 2338 | 8141 | 0.2872 | 0.6547 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 87.86 | 84.90 | 3096 | 7680 | 0.4031 | 0.7391 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 87.86 | 84.90 | 3140 | 7680 | 0.4088 | 0.7429 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 87.86 | 84.90 | 223 | 7680 | 0.0290 | 0.1602 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 87.86 | 84.90 | 2359 | 7680 | 0.3072 | 0.6678 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 89.57 | 84.90 | 3207 | 7494 | 0.4279 | 0.7539 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 89.57 | 84.90 | 3261 | 7494 | 0.4351 | 0.7584 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 89.57 | 84.90 | 212 | 7494 | 0.0283 | 0.1521 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 89.57 | 84.90 | 2415 | 7494 | 0.3222 | 0.6786 | MN20160318_Q02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 91.27 | 84.90 | 3213 | 7420 | 0.4330 | 0.7566 | MN20160318_Q02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 91.27 | 84.90 | 3263 | 7420 | 0.4398 | 0.7608 | MN20160318_Q02 | G10 |